Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4792095
Max Phase: Preclinical
Molecular Formula: C44H54N12O10S
Molecular Weight: 943.06
Molecule Type: Unknown
Associated Items:
ID: ALA4792095
Max Phase: Preclinical
Molecular Formula: C44H54N12O10S
Molecular Weight: 943.06
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)c([N+](=O)[O-])c1)C(=O)N[C@@H](CS)C(N)=O
Standard InChI: InChI=1S/C44H54N12O10S/c45-14-6-5-11-31(41(61)53-32(42(62)55-35(22-67)39(48)59)15-23-12-13-37(57)36(16-23)56(65)66)51-43(63)34(18-25-21-50-30-10-4-2-8-27(25)30)54-44(64)33(52-40(60)28(46)19-38(47)58)17-24-20-49-29-9-3-1-7-26(24)29/h1-4,7-10,12-13,16,20-21,28,31-35,49-50,57,67H,5-6,11,14-15,17-19,22,45-46H2,(H2,47,58)(H2,48,59)(H,51,63)(H,52,60)(H,53,61)(H,54,64)(H,55,62)/t28-,31-,32-,33-,34-,35-/m0/s1
Standard InChI Key: WCWHFQQUOOQBDX-DATVRVMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 943.06 | Molecular Weight (Monoisotopic): 942.3807 | AlogP: -0.54 | #Rotatable Bonds: 25 |
Polar Surface Area: 378.67 | Molecular Species: BASE | HBA: 13 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 6.75 | CX Basic pKa: 10.38 | CX LogP: -1.65 | CX LogD: -1.82 |
Aromatic Rings: 5 | Heavy Atoms: 67 | QED Weighted: 0.02 | Np Likeness Score: 0.02 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):